DSV Panalpina A/S
Company Announcement No. 860
On 29 October 2020, we initiated a share buyback programme, as described in Company Announcement No. 842 of 29 October 2020. According to the programme, the company will in the period from 29 October 2020 to 30 April 2021 purchase own shares up to a maximum value of DKK 6,000,000,000 and no more than 12,000,000 shares, corresponding to 5.22% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules.
| Trading day | Number of shares bought back | Average transaction price | Amount DKK | ||||
| Accumulated trading for days 1-63 | 3,677,432 | 1,007.34 | 3,704,431,358 | ||||
| 64: | 1 February 2021 | 55,000 | 975.34 | 53,643,607 | |||
| 65: | 2 February 2021 | 60,000 | 995.84 | 59,750,370 | |||
| 66: | 3 February 2021 | 61,000 | 1,003.85 | 61,234,819 | |||
| 67: | 4 February 2021 | 48,673 | 1,014.82 | 49,394,334 | |||
| 68: | 5 February 2021 | 56,417 | 1,016.75 | 57,361,708 | |||
| Accumulated trading for days 1-68 | 3,958,522 | 1,006.90 | 3,985,816,196 | ||||
As at today, DSV Panalpina A/S holds a total of 5,845,538 shares of a nominal value of DKK 1 in DSV Panalpina A/S, corresponding to 2.54% of the total number of issued shares of 230,000,000.
The details of each transaction made under the share buyback programme are published on investor.dsv.com.
Any questions may be addressed to Executive Vice President, Investor Relations, Flemming Ole Nielsen, tel. +45 43 20 33 92.
Yours sincerely,
DSV Panalpina A/S
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ALK Abello19.12.2025 22:46:46 CET | Press release
Major shareholder announcement
ALK Abello19.12.2025 22:46:46 CET | Pressemeddelelse
Storaktionærmeddelelse
Zealand Pharma19.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Boehringer Ingelheim Limited19.12.2025 21:10:00 CET | Press release
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
Novartis Pharma AG19.12.2025 20:30:06 CET | Press release
Novartis and US government reach agreement on lowering drug prices in the US
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
